A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
Imugene Limited
Imugene Limited
Alaunos Therapeutics
Numab Therapeutics AG
Novartis
Janssen Research & Development, LLC
Rain Oncology Inc
Turning Point Therapeutics, Inc.
Ikena Oncology
Ikena Oncology
Innovent Biologics (Suzhou) Co. Ltd.
Helix BioPharma Corporation
Novartis
Myriad Genetic Laboratories, Inc.
Pathway Genomics
Pharmacyclics LLC.
Agennix